z-logo
open-access-imgOpen Access
Functionality and Performance of an Accessorized Pre-Filled Syringe and an Autoinjector for At-Home Administration of Tezepelumab in Patients with Severe, Uncontrolled Asthma
Author(s) -
Sady Alpizar,
Ayman Megally,
Claudia Chen,
Abhi Raj,
J. A. Downie,
Gene Colice
Publication year - 2021
Publication title -
journal of asthma and allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.162
H-Index - 30
ISSN - 1178-6965
DOI - 10.2147/jaa.s305114
Subject(s) - medicine , asthma , clinical endpoint , syringe , randomized controlled trial , adverse effect , psychiatry
Tezepelumab is an anti-thymic stromal lymphopoietin monoclonal antibody in development for the treatment of severe asthma. This study assessed the functionality and performance of an accessorized pre-filled syringe (APFS) and an autoinjector (AI) for administration of tezepelumab in the clinic and at home.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here